RxDoctor Payments Data

Jason Cohen, MD

Plastic Surgery within the Head & Neck · Poughkeepsie, NYNPI 1851401152

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. GSK accounts for 62.7% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $349, 3.7 times the $94 reported in 2019. That places this record below the midpoint for plastic surgery within the head & neck clinicians in NY, where the typical reported total is $1,306.

$571in general payments, 2019–2025

Across 26 payments — averaging $21.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$358
  • Stryker$58
  • Hikma Pharmaceuticals USA$51
  • Medtronic$36
  • AstraZeneca$30
  • Inspire Medical Systems, Inc.$24
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$571100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$571 in reported general payments places this provider in the 20th percentile of 45 plastic surgery within the head & neck providers in New York.

See all plastic surgery within the head & neck providers in New York

Medicare billing

Part B allowed, 2024
$272,731
Medicare patients
987
Services billed
2,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl141$7,497
Fluticasone Propionate110$2,261
Omeprazole18$260
Pantoprazole Sodium19$217
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$165
Famotidine12$118

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →